S&T Bank’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

S&T Bank’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-505,364	Closed	-$2.02M	–	111
2019 Q4	$2.02M	Sell	505,364 -141,447	-22%	-$664K	0.41%	61
2019 Q3	$3.2M	Buy	646,811 +36,444	+6%	+$204K	0.69%	46
2019 Q2	$3.72M	Buy	610,367 +58,747	+11%	+$312K	0.81%	47
2019 Q1	$3.2M	Buy	551,620 +105,332	+24%	+$1.09M	0.72%	48
2018 Q4	$6.01M	Buy	+446,288	New	+$7.52M	1.39%	34

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

S&T Bank's DPLO Position: Q1 2020 in Review

S&T Bank sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 505,364 shares — an estimated $2.02M sold.

S&T Bank first reported a position in DPLO in Q4 2018 and held it in 5 quarters. The position peaked at $6.01M in Q4 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

S&T Bank reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
S&T Bank sold 505,364 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.02M.
S&T Bank first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2018 and held it in 5 quarters.
S&T Bank's DIPLOMAT PHARMACY, INC. position peaked at $6.01M in Q4 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on S&T Bank's 13F filing for Q1 2020, filed 14 May 2020.